Page last updated: 2024-10-28

ifenprodil and Apoplexy

ifenprodil has been researched along with Apoplexy in 3 studies

ifenprodil: NMDA receptor antagonist

Research Excerpts

ExcerptRelevanceReference
" In this context, we analyzed the effect of Ifenprodil, an NR2b selective NMDAR antagonist and its combination at lower doses with flurbiprofen, a selective ASIC1a inhibitor on rat model of focal cerebral ischemia."3.77The neuroprotective effects of NMDAR antagonist, ifenprodil and ASIC1a inhibitor, flurbiprofen on post-ischemic cerebral injury. ( Mishra, V; Raghubir, R; Singh, N; Verma, R, 2011)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Xu, Q1
Hu, M1
Li, J1
Ma, X1
Chu, Z1
Zhu, Q1
Zhang, Y1
Zhu, P1
Huang, Y1
He, G1
Mishra, V1
Verma, R1
Singh, N1
Raghubir, R1
Bhattacharya, P1
Pandey, AK1
Paul, S1
Patnaik, R1

Other Studies

3 other studies available for ifenprodil and Apoplexy

ArticleYear
Discovery of novel brain-penetrant GluN2B NMDAR antagonists via pharmacophore-merging strategy as anti-stroke therapeutic agents.
    European journal of medicinal chemistry, 2022, Jan-05, Volume: 227

    Topics: Benzofurans; Brain; Dose-Response Relationship, Drug; Drug Discovery; Humans; Molecular Structure; N

2022
The neuroprotective effects of NMDAR antagonist, ifenprodil and ASIC1a inhibitor, flurbiprofen on post-ischemic cerebral injury.
    Brain research, 2011, May-10, Volume: 1389

    Topics: Animals; Apoptosis; Brain Ischemia; Drug Therapy, Combination; Flurbiprofen; In Situ Nick-End Labeli

2011
Combination therapy of ifenprodil with piroxicam may be an effective therapeutic intervention in cerebral stroke: a hypothesis.
    Medical hypotheses, 2012, Volume: 79, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Humans; Models, Neurolo

2012